Wednesday, July 9, 2014

Top Healthcare Technology Companies To Own In Right Now

The wait for the turnaround in the steel industry has been a challenging one for shareholders. While some companies, including U.S. minimill operators Steel Dynamics (Nasdaq:STLD) and Nucor (NYSE:NUE) and foreign producers like Ternium (NYSE:TX) have seen their shares turn around, other steelmakers like ArcelorMittal (NYSE:MT), U.S. Steel (NYSE:X), and Gerdau (NYSE:GGB) have had a rougher go of it.

Sentiment seems to be turning around for Brazil-based Gerdau. Steel companies there are having more success in pushing through higher prices and demand has been pretty solid from customers in autos, aviation, and other types of heavy industry. What's interesting, though, is that sell-side enthusiasm isn't really reflected in their estimates, and Gerdau doesn't look all that cheap on a near-term numbers basis. While improving conditions in Brazil and a pick-up in the U.S. could definitely lead to upward estimate revisions, the bull case does require investors to look out beyond just the next 12 to 18 months of EBITDA.

Top 10 International Stocks For 2015: Intermolecular Inc (IMI)

Intermolecular, Inc. (Intermolecular), incorporated on June 16, 2004, is engaged in research and development and time-to-market for the semiconductor and clean-energy industries. The Company, through paid collaborative development programs (CDPs) with its customers, develops technology and intellectual property (IP) for its customers focused on advanced materials, processes, integration and device architectures. The Company provides its customers with technology through various fee arrangements and grants them rights to associated IP, primarily through royalty-bearing licenses. Through paid CDPs and its own development, the Company has established a portfolio of greater than 1,000 patents and patent applications. Its approach is broadly applicable to high-volume integrated device markets, which include the markets for semiconductors, flat glass coatings and glass-based devices, solar cells, light-emitting diodes (LEDs), flat-panel displays, advanced batteries and other energy efficiency applications.

As of December 31, 2012, the Company targets large, high-volume semiconductor and high-growth emerging clean energy markets, including DRAM, non-volatile memory (including flash memory and embedded memory), complex logic, flat glass coatings and glass-based devices, solar cells, LEDs and other energy efficiency applications. The Company�� customers include ATMI, Inc. (ATMI), Elpida Memory, Inc. (Elpida), First Solar. Inc. (First), GLOBALFOUNDRIES Singapore Pte. Ltd (GLOBALFOUNDRIES), Guardian Industries Corp. (Guardian), SanDisk Corporation (SanDisk), Taiwan Semiconductor Manufacturing Company (TSMC) and Toshiba Corporation (Toshiba). For the year ended December 31, 2012, the Company has received the majority of its revenue from customers in DRAM, flash memory, complex logic and energy-efficient applications in flat glass. The elements in HPC platform include Tempus HPC processing, automated characterization, and informatics and analysis software. Tempus HPC processing are used to process ! different experiments consisting of combinations of materials, processing parameters, sequencing and device structures. Automated characterization systems are used to characterize the substrates processed by its Tempus HPC processing tools. Informatics and analysis software are used to automate experiment generation, characterization, data analysis and reporting.

The Company�� HPC platform consists of its Tempus HPC processing tools, automated characterization and informatics and analysis software. The Company�� platform is purpose-built for Research and Development (R and D) using combinatorial process systems. Combinatorial processing is a methodology for discovery and development that employs parallel and other high-throughput experimentation, which allows R and D experimentation to be performed at speeds up to 100 times faster than traditional methods. The Company�� processing tools allows performing up to 192 experiments on a single substrate.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent.

  • [By Sofia Horta e Costa]

    ARM Holdings Plc (ARM) lost 2.6 percent, leading European technology companies lower before it publishes half-year results next week. IMI Plc (IMI) gained 2 percent as Citigroup Inc. listed the engineering company among its most preferred stocks.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Technology shares gained about 0.68 percent in today's trading. Meanwhile, top gainers in the sector included Intermolecular (NASDAQ: IMI), up 38.3 percent, and Infinera (NASDAQ: INFN), up 9.4 percent. In trading on Monday, utilities shares were relative laggards, down on the day by about 0.68 percent.

  • [By Lisa Levin]

    Intermolecular (NASDAQ: IMI) shares touched a new 52-week low of $4.84. Intermolecular shares have dropped 45.09% over the past 52 weeks, while the S&P 500 index has gained 26.39% in the same period.

Top Healthcare Technology Companies To Own In Right Now: Centene Corporation (CNC)

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Medicaid Managed Care and Specialty Services. The Medicaid Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through government subsidized programs, including Medicaid, the State children�s health insurance program, long-term care, foster care, and Medicare special needs plans, as well as aged, blind, or disabled programs. Its health plans provide primary and specialty physician care, inpatient and outpatient hospital care, transportation assistance, emergency and urgent care, vision care, prenatal care, dental care, laboratory and x-ray services, immunizations, prescriptions and over-the-counter drugs, home health and durable medical equipment, behavioral health and substance abuse services, therapies, social work services, care coordination, and 24-hour nurse advice line. The Specialty Services segment manages behavioral healthcare for members; provides health insurance to individual customers and their families; implements life and health management programs; offers long-term care services to the elderly and people with disabilities; and administers routine and medical surgical eye care benefits through its network of eye care providers. It also offers telehealth services; and claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, specialty and mail order pharmacy services, and patient and physician intervention services, as well as provides care management solutions that automate the clinical, administrative, and technical components of care management programs. The company offers its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Shares of Centene (NYSE: CNC) got a boost, shooting up 9.77 percent to $62.89 on upbeat quarterly results. Centene reported its Q1 earnings of $0.57 per share on revenue of $3.46 billion.

  • [By Jake L'Ecuyer]

    Shares of Centene (NYSE: CNC) got a boost, shooting up 12.72 percent to $64.58 on upbeat quarterly results. Centene reported its Q1 earnings of $0.57 per share on revenue of $3.46 billion.

  • [By Monica Gerson]

    Breaking news

    Whirlpool (NYSE: WHR) reported a strong rise in its third-quarter earnings. For the year, Whirlpool lifted its earnings forecast to $9.90 to $10.10 per share, versus its July outlook of $9.50 to $10 per share. To read the full news, click here. Questcor Pharmaceuticals (NASDAQ: QCOR) announced today that it will commence a Phase 2 study to explore the efficacy and safety of H.P. Acthar庐 Gel (repository corticotropin injection) for Acute Respiratory Distress Syndrome (ARDS). To read the full news, click here. Centene (NYSE: CNC) reported a stronger-than-expected third-quarter profit. Centene's quarterly net earnings surged to $49.4 million, or $0.87 per share, up from $3.8 million, or $0.07 per share, in the year-ago period. To read the full news, click here. Dwolla and Alliance Data Systems (NYSE: ADS) today announced they have signed a new, multi-year agreement for Alliance Data's Retail Services business to provide a cardless private label credit product for the Dwolla payment network. To read the full news, click here.

    Posted-In: Morgan Stanley US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

  • [By Holly LaFon]

    Importantly, we like the industry in which Centene (CNC) competes. Some of our investors might recall that one of our prior investments, Amerigroup, was acquired in 2012 by Wellpoint at a val uation that allowed us to achieve a return on investment of greater than 100% over the roughly one - year time period that we owned the shares. Medicaid managed care companies not only save states money but also offer better service; therefore, more states a re letting managed care companies run their Medicaid programs. To that end, states are expanding both the geographies carved out to managed care companies and the types of programs. The next phase of growth will come from the dual - eligible population. D uals (or dual - eligible population) are 8.3mm 3 people in the U.S. that are eligible to receive both Medicare and Medicaid benefits (mainly low - income seniors). According to the Kaiser Foundation, Duals accounted for almost 40% of Medicaid spending although they made up only 15% of the Medicaid population. We believe there are ample growth opportunities for CNC and other companies to meet the challenges of managing these disparate Medicaid members for the foreseeable future.

Top Healthcare Technology Companies To Own In Right Now: Bombardier Inc (BDRAF)

Bombardier, Inc. is a Canada-based aerospace and transportation company. The Company operates in two segments: aerospace and rail transportation. The aerospace segment is structured by market segment (business aircraft, commercial aircraft and services), which is reflective of its organizational structure. The transportation segment is structured by market segment (rolling stock, services, system and signalling), which is reflective of its organizational structure, and by geographic region (Europe, North America, Asia-Pacific and Rest of world). As of December 31, 2012, the Company had 80 production and engineering sites in 26 countries, and a worldwide network of service centre. In May 2012, it launched the Learjet 70 and Learjet 75 aircraft programs. In October 2013, the Company announced that it has opened Bombardier's new wing manufacturing and assembly facility in Belfast. In December 2013, the Company sold Flexjet's activities to Flexjet, LLC. Advisors' Opinion:
  • [By Adam Levine-Weinberg]

    Yet there is a fourth major competitor in the commercial aircraft market -- Bombardier (NASDAQOTH: BDRAF  ) -- and it has its own advanced-technology airplane. The company's CSeries plane is expected to make its first flight as early as this week. Yet the CSeries put up a goose egg at the Paris Air Show, failing to notch a single order. While Bombardier has nearly 200 firm orders for the CSeries, the company will rapidly burn through that backlog once it starts CSeries mass production.

Top Healthcare Technology Companies To Own In Right Now: BlackRock Enhanced Capital And Income Fund Inc (CII)

BlackRock Enhanced Capital and Income Fund, Inc. (the Fund), formerly BlackRock Capital and Income Strategies Fund, Inc., is a diversified, closed-end management investment company. The Fund seeks to provide current income and capital appreciation. It invests in a portfolio of equity and debt securities of United States and foreign issuers. The Fund�� portfolio includes common stocks, preferred stocks, foreign government obligations, corporate bonds, trust preferreds and municipal bonds. The Fund employs a strategy of writing (selling) call options on equity indexes in an attempt to generate gains from option premiums (the Index Option Strategy). Under the Index Option Strategy, the Fund will write call options primarily on the S&P 500 Index, but may, from time to time, write call options on other equity indexes as well. The Fund�� investment advisor is BlackRock Advisors, LLC, an indirect, wholly owned subsidiary of BlackRock, Inc.

The Fund invests in various industries, including commercial banks, diversified financial services, electric utilities, food products, gas utilities, insurance, thrifts and mortgage finance, and real estate investment trusts. On September 29, 2006, BlackRock, Inc. and Merrill Lynch & Co., Inc. (Merrill Lynch) combined Merrill Lynch�� investment management business, Merrill Lynch Investment Managers, L.P. (MLIM), and its affiliates, including Fund Asset Management, L.P. (FAM), with BlackRock, Inc. to create an independent company. Merrill Lynch has a 49.8% economic interest and a 45% voting interest in the combined company, and The PNC Financial Services Group, Inc. (PNC) has approximately a 34% economic and voting interest. The new company operates under the BlackRock name.

Advisors' Opinion:
  • [By Dividends4Life]

    According to a Gabelli Funds report, managed distribution policies offer several advantages, including:1. Lower difference between the fund�� market price and its NAV per share.2. Provides support during periods when the stock market is in a decline.3. Provides a measurable performance target for the investment adviser.Below are several high-yield funds from CEFA that have a managed distribution policy (yields as of December 16):Aberdeen Australia Eqty (IAF)- Distribution Yield: 10.4%- Income Yield: 3.46%Bexil Advisers LLC� (DNI)- Distribution Yield: 11.1%- Income Yield: 3.56%BlackRock En Capital&Inc (CII)- Distribution Yield: 8.78%- Income Yield: 2.34%Cornerstone Strat Value (CLM)- Distribution Yield: 18.77%- Income Yield: 1.83%Cornerstone Total Return (CRF)- Distribution Yield: 19.10%- Income Yield: 0.85%Delaware Inv Div & Inc (DDF)- Distribution Yield: 6.70%- Income Yield: 5.26%Gabelli Equity Trust (GAB)- Distribution Yield: 7.58%- Income Yield: 1.54%Gabelli Utility Trust (GUT)- Distribution Yield: 9.45%- Income Yield: 2.84%MFS Special Value Trust (MFV)- Distribution Yield: 9.60%- Income Yield: 5.73%Nuveen Tx-Adv TR Strat (JTA)- Distribution Yield: 6.70%- Income Yield: 3.12%TCW Strategic Income (TSI)- Distribution Yield: 10.54%- Income Yield: 7.88%Zweig Total Return (ZTR)- Distribution Yield: 7.27%- Income Yield: 1.95%As noted in the Gabelli report, a managed distribution policy may create confusion regarding the true current yield since the reported yield includes the return of capital portion. You can see the disparity above between the income yield and the distribution (reported) yield.If you are looking for a sustainable and growing dividend, you may want to consider some blue-chip dividend stocks such as these with a Free Cash Flow Payout less than 50%, 50+ years of consecutive dividend increases and a 2%+ yield:3M Co. (MMM) is a diversified global company provides enhanced product functionality in electronics, health care, industrial, consumer

Top Healthcare Technology Companies To Own In Right Now: Eastern Virginia Bankshares Inc.(EVBS)

Eastern Virginia Bankshares, Inc. operates as the holding company for EVB, a state-chartered community bank that provides a range of personal and commercial banking services to individuals and small to medium-sized businesses primarily in eastern Virginia. The company offers various interest-bearing deposits, including checking, savings, money market, and certificate of deposit and other time deposit accounts, as well as noninterest-bearing demand deposits. It also provides commercial business, industrial, agricultural, one-to-four family residential real estate, multi-family residential real estate, construction, farmland, non-farm and non-residential real estate, and consumer loans. In addition, the company, through the subsidiaries of its bank, offers investment brokerage services; originates and sells residential mortgages; underwrites and sells title insurance to mortgage loan customers; and sells various insurance products as an agent. As of December 31, 2010, it own ed and operated 24 full-service branch offices that serve customers in Caroline, Essex, Gloucester, Hanover, Henrico, King and Queen, King William, Lancaster, Middlesex, New Kent, Richmond, Northumberland, Southampton, Surry, and Sussex counties, as well as in the city of Colonial Heights. The company was founded in 1910 and is headquartered in Tappahannock, Virginia.

Advisors' Opinion:
  • [By Bristol Voss]

    Eastern Virginia Bankshares (Nasdaq: EVBS) is a bank holding company. It received $24 million in financial bailout funds, but it's been released from its agreement with regulators because it raised enough money through private placement. Its $66.7 million market cap puts it in the middle of the group, although its share price is currently the lowest at just over $6. It has a forward P/E of 9.2, but its 1.1% dividend yield is the least of the three. Net income and earnings were down for the most recent quarter, mainly on charge-offs for non-performing and uncollectible assets and other losses.

Top Healthcare Technology Companies To Own In Right Now: KCG Holdings Inc (KCG)

KCG Holdings, Inc., incorporated on December 26, 2012, is an independent securities firm. The Company offers investors a range of services designed to address trading needs across asset classes, product types and time zones. It has three operating segments: Market Making, Global Execution Services, and Corporate and Other. On July 1, 2013, the Company announced the completion of the merger whereby Knight Capital Group, Inc. (Knight) and GETCO Holding Company, LLC (GETCO) were combined as part of KCG Holdings, Inc., a new holding company.

Market Making

The Company�� Market Making segment principally consists of market making in global equities and listed domestic options. As a market maker, the Company commits capital for trade executions by offering to buy securities from, or sell securities to, institutions and broker-dealers. The Market Making segment primarily includes client, and to a lesser extent, non-client market making activities in which the Company operates as a market maker in equity securities quoted and traded on the Nasdaq Stock Market; the over-the-counter (OTC) market for New York Stock Exchange (NYSE), NYSE Amex Equities (NYSE Amex), NYSE Arca listed securities, and several European exchanges. As a complement to electronic market making, the Company�� cash trading business handles specialized orders and also transacts on the OTC Bulletin Board, marketplaces operated by the OTC Markets Group Inc. and the Alternative Investment Market (AIM) of the London Stock Exchange. The segment also provides trade executions as an equities Designated Market Maker (DMM) on the NYSE and NYSE Amex. The Market Making segment also includes the Company�� option market making business which trades on all domestic electronic exchanges.

Global Execution Services

The Company�� Global Execution Services segment offers access through its electronic agency-based platforms to markets and self-directed trading in equities, options, fixed income, foreign ! exchange and futures. The Global Execution Services segment generally does not act as a principal to transactions that are executed within this segment however, it will commit capital on behalf of clients, as needed, and generally earns commissions for acting as agent between the principals to the trade. Global Execution Services includes equity sales and trading (including exchange traded funds (ETFs)), reverse mortgage origination and securitization and asset management. This segment also facilitates client orders through program, block, and riskless principal trades and provides capital markets services, including equity offerings, as well as private placements. The Global Execution Services segment also includes the futures commission merchant (FCM) business, which consists of certain assets and liabilities that the Company acquired or assumed from the futures division of Penson Financial Services, Inc.

Corporate and Other

The Corporate and Other segment invests in strategic financial services-oriented opportunities, allocates, deploys and monitors all capital, and maintains corporate overhead expenses and all other income and expenses that are not attributable to the other segments. The Corporate and Other segment houses functions that support the Company�� other segments, such as self-clearing services, including stock lending activities.

The Company competes with BGC Partners (BGCP), Chicago Board Options Exchange (CBOE), CME (CME), GFI Group Inc. (GFIG), ICE (ICE), ITG (ITG), Forex Capital Markets (FXCM), MarketAxess (MKTX), National Association of Securities Dealers Automated Quotations (NASDAQ), and NYSE.

Advisors' Opinion:
  • [By Sam Mamudi]

    Knight, which in July joined with Getco LLC to form KCG Holdings Inc. (KCG) after losing more than $460 million because of the error, agreed to settle charges stemming from mistakes made on Aug. 1, 2012, according to a statement today from the U.S. Securities and Exchange Commission. The regulator said Knight violated the SEC�� market access rule, instituted in 2010 to prevent these kinds of trading missteps.

Top Healthcare Technology Companies To Own In Right Now: Gen-Probe Incorporated(GPRO)

Gen-Probe Incorporated engages in the development, manufacture, and marketing of molecular diagnostic products and services that are used primarily to diagnose human diseases and screen donated human blood. Its women?s health product line includes APTIMA Combo 2 assay, APTIMA CT, APTIMA GC assays, and PACE family of assays to detect chlamydia and gonorrhea; APTIMA Trichomonas ASRs to detect trichomonas; APTIMA HPV assay to detect 14 sub-types of high-risk HPV associated with cervical cancer; and AccuProbe Group B Streptococcus (GBS) assay to detect GBS from culture. The company?s infectious diseases product line comprises ProFlu+ to detect influenza A, B, and Respiratory syncytial virus; ProFAST+ to detect and differentiate seasonal H1, seasonal H3, and H1N1pdm09; ProGastro Cd to detect toxigenic strains of clostridium difficile; AMPLIFIED MTD to detect mycobacterium tuberculosis; GAS Direct to detect gas directly from a throat swab; APTIMA HIV-1 and APTIMA HCV assays to detect RNA from HIV-1 and hepatitis C virus; and ASRs for quantitative HCV testing. Its blood screening products include Procleix HIV-1/HCV, Procleix Ultrio, Procleix Ultrio Plus, and Procleix WNV assays to detect HIV-1, HCV, HBV, and west nile virus in donated blood, plasma, organs, and tissues. The company?s transplant diagnostics products comprise LIFECODES HLA DNA typing kits; LIFECODES HLA antibody kits; LIFECODES PF4 assay to detect PF4 heparin-dependent antibodies; and LIFECODES PAK products for platelet antibody screening and detection. It also provides instrumentation and software for performing NAT assays; and genetic testing products, such as PROGENSA PCA3 and PCA3 ASRs to detect the PCA3 genes. The company serves reference laboratories, public health institutions, and hospitals through its direct sales force in United States, Canada, and Europe, as well as through distributors internationally. Gen-Probe Incorporated was founded in 1983 and is headquartered in S an Diego, California.

Advisors' Opinion:
  • [By Steven Russolillo]

    For GoPro Inc.(GPRO), now comes the hard part.

    Bearish investors are out in full force betting against the video-camera maker’s stock price after it more than doubled throughout its first four days on the public markets. Whether GoPro can convince the skeptics of its future prospects will go a long way in determining the stock’s next move.

  • [By Garrett Cook]

    Shares of GoPro (NASDAQ: GPRO) got a boost, shooting up 15.19 percent to $46.71  following an announcement by the Chicago Board Options Exchange (CBOE) that it will list options for GoPro starting Monday, July 7. GoPro shares jumped 13.39% on Monday.

No comments:

Post a Comment